Logo

NEWS

News-Archiv:  
Jul 08, 2013
Grant from Bavarian Research Foundation to Fund Research on PPI Inhibitors for Tumor Therapy

Priaxon and the research group of Prof. Vollmar at the Department of Pharmacy, Center for Drug Research, Ludwig-Maximilians-University, Munich win grant from Bavarian Research Foundation to fund research on PPI inhibitors for tumor therapy.

read more
Jul 03, 2013
Cooperation with Munich Technical University Hospital to Develop Novel Anti-Infectives Extended

Priaxon and the Munich Technical University Hospital Rechts der Isar prolongate their cooperation on the development of new, highly selective anti-infective agents. A second funding period of two years has been granted.

read more
Apr 09, 2013
Lead Discovery Collaboration on Protein Protein Interaction Targets with Proteros

Proteros and Priaxon Announce Lead Discovery Collaboration on Protein Protein Interaction Targets

read more
Feb 04, 2013
Research Collaboration with Ontochem on Orexin Receptor Modulators Covered by ZIM-Grant

Priaxon AG, Munich and Ontochem GmbH, Halle, win grant from Central Innovation Program SME (Zentrales Innovationsprogramm Mittelstand - ZIM) to research and develop Orexin receptor agonists for the treatment of pain.

read more
Jan 07, 2013
Priaxon Enters Collaboration with GSK on Protein-Protein-Interactions

Priaxon announces a collaboration with GlaxoSmithKline (GSK) to establish and develop novel drug discovery approaches to address protein-protein-interactions with small molecules

read more
Jan 24, 2012
Boehringer Ingelheim prolongates drug discovery collaboration with Priaxon

Priaxon, utilizing its proprietory PriaXploreŽ platform for small molecule drug discovery, and Boehringer Ingelheim will prolongate their research and development collaboration on mdm2/p53 inhibitors for the treatment of cancer.

read more
Oct 12, 2011
Ontochem and Priaxon Join Forces to Increase Stress Tolerance of Crops

Ontochem GmbH and Priaxon AG, Munich, Germany today announced the entry into a collaboration and commercialization agreement to obtain new superior inhibitors of the plant PARP, poly(ADP-ribose)polymerase enzyme. The goal of this collaboration is to increase the intrinsic stress tolerance of agricultural crops and accordingly minimizing growth losses by abiotic stress.

read more
Nov 08, 2010
Cooperation with Munich Technical University Hospital to develop novel anti-infectives

Priaxon and Munich Technical University Hospital announce cooperation for the development of novel anti-infectives with novel mode of action

read more
Jun 14, 2010
Faron and Priaxon: Cardiovascular Deseases Research Collaboration in the field of PPI

Faron and Priaxon announce a collaboration to generate a new class of AOC3/SSAO antagonists

read more
Apr 22, 2010
Drug Discovery Chemistry being held April 27-29th in San Diego, CA

Meet Priaxon at Drug Discovery Chemistry, April 27-29th in San Diego, CA

read more